Kevin Rassas
CIK 1464548 · View on SEC EDGAR ↗
Insider
First SEC filing: June 3, 2009 · Latest: June 3, 2009
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 13 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 16, 2009 | INO | M | 117,744 | $0.31 | $36,501 | 0 Direct | -100.00% | Disposed | -91.5% (price as of 2026-08-20) |
| Nov. 16, 2009 | INO | M | 392,480 | $0.20 | $78,496 | 0 Direct | -100.00% | Disposed | -86.9% (price as of 2026-08-20) |
| Nov. 16, 2009 | INO | M | 98,120 | $0.05 | $4,906 | 98,120 Direct | -50.00% | Disposed | -47.5% (price as of 2026-08-20) |
| Nov. 16, 2009 | INO | M | 117,744 | $0.31 | $36,501 | 726,088 Direct | +19.35% | Acquired | -91.5% (price as of 2026-08-20) |
| Nov. 16, 2009 | INO | M | 392,480 | $0.20 | $78,496 | 608,344 Direct | +181.82% | Acquired | -86.9% (price as of 2026-08-20) |
| Nov. 16, 2009 | INO | M | 98,120 | $0.05 | $4,906 | 215,864 Direct | +83.33% | Acquired | -47.5% (price as of 2026-08-20) |
| Nov. 16, 2009 | INO | M | 117,744 | $0.31 | $36,501 | 0 Direct | -100.00% | Disposed | -91.5% (price as of 2026-08-20) |
| Nov. 16, 2009 | INO | M | 392,480 | $0.20 | $78,496 | 0 Direct | -100.00% | Disposed | -86.9% (price as of 2026-08-20) |
| Nov. 16, 2009 | INO | M | 98,120 | $0.05 | $4,906 | 98,120 Direct | -50.00% | Disposed | -47.5% (price as of 2026-08-20) |
| Nov. 16, 2009 | INO | M | 117,744 | $0.31 | $36,501 | 726,088 Direct | +19.35% | Acquired | -91.5% (price as of 2026-08-20) |
| Nov. 16, 2009 | INO | M | 392,480 | $0.20 | $78,496 | 608,344 Direct | +181.82% | Acquired | -86.9% (price as of 2026-08-20) |
| Nov. 16, 2009 | INO | M | 98,120 | $0.05 | $4,906 | 215,864 Direct | +83.33% | Acquired | -47.5% (price as of 2026-08-20) |
| Sept. 30, 2009 | INO | A | 120,000 | $1.57 | $188,400 | 120,000 Direct | — | Acquired | -98.3% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 16, 2009 | INO | Inovio Biomedical Corporation Common Stock Option | Inovio Biomedical Corporation Common Stock (117,744) | $0.31 | Dec. 17, 2015 | 117,744 | Disposed |
| Nov. 16, 2009 | INO | Inovio Biomedical Corporation Common Stock Option | Inovio Biomedical Corporation Common Stock (392,480) | $0.20 | Dec. 1, 2014 | 392,480 | Disposed |
| Nov. 16, 2009 | INO | Inovio Biomedical Corporation Common Stock Option | Inovio Biomedical Corporation Common Stock (98,120) | $0.05 | Dec. 16, 2013 | 98,120 | Disposed |
| Nov. 16, 2009 | INO | Inovio Biomedical Corporation Common Stock Option | Inovio Biomedical Corporation Common Stock (117,744) | $0.31 | Dec. 17, 2015 | 117,744 | Disposed |
| Nov. 16, 2009 | INO | Inovio Biomedical Corporation Common Stock Option | Inovio Biomedical Corporation Common Stock (392,480) | $0.20 | Dec. 1, 2014 | 392,480 | Disposed |
| Nov. 16, 2009 | INO | Inovio Biomedical Corporation Common Stock Option | Inovio Biomedical Corporation Common Stock (98,120) | $0.05 | Dec. 16, 2013 | 98,120 | Disposed |
| Sept. 30, 2009 | INO | Common Stock Options | Common Stock (120,000) | $1.57 | Sept. 30, 2019 | 120,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 3, 2009 | INO | Inovio Biomedical Corporation Common Stock [F1] | 117,744 | Direct |
| June 3, 2009 | INO | Inovio Biomedical Corporation Stock Option [F2,F3]→ Inovio Biomedical Corporation Common Stock (196,240) | 196,240 | Direct |
| June 3, 2009 | INO | Inovio Biomedical Corporation Stock Option [F2,F3]→ Inovio Biomedical Corporation Common Stock (392,480) | 392,480 | Direct |
| June 3, 2009 | INO | Inovio Biomedical Corporation Stock Option [F2,F3]→ Inovio Biomedical Corporation Common Stock (117,744) | 117,744 | Direct |
| June 3, 2009 | INO | Inovio Biomedical Corporation Stock Option [F2,F3,F4]→ Inovio Biomedical Corporation Common Stock (29,436) | 29,436 | Direct |
| June 3, 2009 | INO | Inovio Biomedical Corporation Stock Option [F2,F3,F5]→ Inovio Biomedical Corporation Common Stock (49,060) | 49,060 | Direct |
| June 3, 2009 | INO | Inovio Biomedical Corporation Stock Option [F2,F3,F6]→ Inovio Biomedical Corporation Common Stock (14,718) | 14,718 | Direct |
| June 3, 2009 | INO | Inovio Biomedical Corporation Stock Option [F2,F3,F7]→ Inovio Biomedical Corporation Common Stock (19,624) | 19,624 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2009 | $107,237 | $56,250 | — | $48,469 | — | — | — | $211,956 |
| 2008 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.